Clinical Trial Update: Avelumab Plus Autologous Dendritic Cell Vaccine in Pre-treated Metastatic Colorectal Cancer Patients [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating avelumab with an autologous dendritic cell vaccine in pre-treated metastatic colorectal cancer completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Carcinoma

Drugs mentioned

• Avelumab (avelumab)

Snippet

Sponsor: Grupo Espanol Multidisciplinario del Cancer Digestivo | Conditions: Colorectal Carcinoma | Phase 1, Phase 2 | Status: COMPLETED